Arterial spin labeled perfusion MRI for the assessment of radiation-treated meningiomas

被引:0
|
作者
Manning, Paul [1 ,2 ]
Srinivas, Shanmukha [2 ]
Bolar, Divya S. [1 ,3 ]
Rajaratnam, Matthew K. [2 ]
Piccioni, David E. [4 ]
McDonald, Carrie R. [2 ,4 ,5 ]
Hattangadi-Gluth, Jona A. [6 ]
Farid, Nikdokht [1 ,2 ,3 ]
机构
[1] Univ Calif San Diego, Dept Radiol, San Diego, CA 92093 USA
[2] Univ Calif San Diego, Ctr Multimodal Imaging & Genet, San Diego, CA 92093 USA
[3] Univ Calif San Diego, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Neurosci, San Diego, CA USA
[5] Univ Calif San Diego, Dept Psychiat, San Diego, CA USA
[6] Univ Calif San Diego, Dept Radiat Med & Appl Sci, La Jolla, CA USA
来源
FRONTIERS IN RADIOLOGY | 2024年 / 4卷
关键词
ASL; arterial spin labeled; perfusion; CBF; cerebral blood flow; meningioma; RESPONSE ASSESSMENT; SKULL BASE; INTRACRANIAL MENINGIOMAS; TUMOR-CONTROL; BENIGN; CRITERIA; RADIOSURGERY; RADIOTHERAPY; RESECTION; RECURRENCE;
D O I
10.3389/fradi.2024.1345465
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Conventional contrast-enhanced MRI is currently the primary imaging technique used to evaluate radiation treatment response in meningiomas. However, newer perfusion-weighted MRI techniques, such as 3D pseudocontinuous arterial spin labeling (3D pCASL) MRI, capture physiologic information beyond the structural information provided by conventional MRI and may provide additional complementary treatment response information. The purpose of this study is to assess 3D pCASL for the evaluation of radiation-treated meningiomas. Methods: Twenty patients with meningioma treated with surgical resection followed by radiation, or by radiation alone, were included in this retrospective single-institution study. Patients were evaluated with 3D pCASL and conventional contrast-enhanced MRI before and after radiation (median follow up 6.5 months). Maximum pre- and post-radiation ASL normalized cerebral blood flow (ASL-nCBF) was measured within each meningioma and radiation-treated meningioma (or residual resected and radiated meningioma), and the contrast-enhancing area was measured for each meningioma. Wilcoxon signed-rank tests were used to compare pre- and post-radiation ASL-nCBF and pre- and post-radiation area. Results: All treated meningiomas demonstrated decreased ASL-nCBF following radiation (p < 0.001). Meningioma contrast-enhancing area also decreased after radiation (p = 0.008) but only for approximately half of the meningiomas (9), while half (10) remained stable. A larger effect size (Wilcoxon signed-rank effect size) was seen for ASL-nCBF measurements (r = 0.877) compared to contrast-enhanced area measurements (r = 0.597). Conclusions: ASL perfusion may provide complementary treatment response information in radiation-treated meningiomas. This complementary information could aid clinical decision-making and provide an additional endpoint for clinical trials.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] Turbo-FLASH Based Arterial Spin Labeled Perfusion MRI at 7 T
    Zuo, Zhentao
    Wang, Rui
    Zhuo, Yan
    Xue, Rong
    St Lawrence, Keith S.
    Wang, Danny J. J.
    PLOS ONE, 2013, 8 (06):
  • [12] ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusion
    Adebimpe, Azeez
    Bertolero, Maxwell
    Dolui, Sudipto
    Cieslak, Matthew
    Murtha, Kristin
    Baller, Erica B.
    Boeve, Bradley
    Boxer, Adam
    Butler, Ellyn R.
    Cook, Phil
    Colcombe, Stan
    Covitz, Sydney
    Davatzikos, Christos
    Davila, Diego G.
    Elliott, Mark A.
    Flounders, Matthew W.
    Franco, Alexandre R.
    Gur, Raquel E.
    Gur, Ruben C.
    Jaber, Basma
    McMillian, Corey
    Milham, Michael
    Mutsaerts, Henk J. M. M.
    Oathes, Desmond J.
    Olm, Christopher A.
    Phillips, Jeffrey S.
    Tackett, Will
    Roalf, David R.
    Rosen, Howard
    Tapera, Tinashe M.
    Tisdall, M. Dylan
    Zhou, Dale
    Esteban, Oscar
    Poldrack, Russell A.
    Detre, John A.
    Satterthwaite, Theodore D.
    NATURE METHODS, 2022, 19 (06) : 683 - +
  • [13] Arterial Spin Labeled Perfusion MRI for Assessing Antiangiogenic Therapy: A Step Forward or Just More Spin?
    Goh, Vicky
    De Vita, Enrico
    RADIOLOGY, 2021, 298 (02) : 341 - 342
  • [14] Arterial spin labeling MRI for assessment of perfusion in native and transplanted kidneys
    Artz, Nathan S.
    Sadowski, Elizabeth A.
    Wentland, Andrew L.
    Grist, Thomas M.
    Seo, Songwon
    Djamali, Arjang
    Fain, Sean B.
    MAGNETIC RESONANCE IMAGING, 2011, 29 (01) : 74 - 82
  • [15] Arterial spin-labeled MRI study of migraine attacks treated with rizatriptan
    Kato, Yuji
    Araki, Nobuo
    Matsuda, Hiroshi
    Ito, Yasuo
    Suzuki, Chihiro
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 (03): : 255 - 258
  • [16] Arterial spin-labeled MRI study of migraine attacks treated with rizatriptan
    Yuji Kato
    Nobuo Araki
    Hiroshi Matsuda
    Yasuo Ito
    Chihiro Suzuki
    The Journal of Headache and Pain, 2010, 11 : 255 - 258
  • [17] Microvascular Perfusion Based on Arterial Spin Labeled Perfusion MRI as a Measure of Vascular Risk in Alzheimer's Disease
    Zhang, Quan
    Stafford, Randall B.
    Wang, Ze
    Arnold, Steven E.
    Wolk, David A.
    Detre, John A.
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 32 (03) : 677 - 687
  • [18] Applications of arterial spin labeled MRI in the brain
    Detre, John A.
    Rao, Hengyi
    Wang, Danny J. J.
    Chen, Yu Fen
    Wang, Ze
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2012, 35 (05) : 1026 - 1037
  • [19] Comparison of cerebral perfusion in AD and ischemic vascular dementia using arterial spin labeled MRI
    Schuff, N
    Matsumoto, S
    Kmiecik, JA
    Studholme, C
    Du, AT
    Miller, BL
    Kramer, JH
    Jagust, WJ
    Chui, HC
    Ezekiel, F
    Weiner, MW
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 327 - 328
  • [20] Cerebral perfusion in AD and subcortical ischemic vascular dementia using arterial spin labeled MRI
    Schuff, N
    Matsumoto, S
    Kmiecik, J
    Studholme, C
    Du, AT
    Miller, BL
    Kramer, JH
    Jagust, WJ
    Chui, HC
    Ezekiel, F
    Weiner, MW
    THIRD INTERNATIONAL CONGRESS ON VASCULAR DEMENTIA, 2003, : 255 - 260